Dr. Florentina Berianu, MD

Dr. Berianu practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Berianu's NPI, 1295988038, was assigned on October 24, 2008. Dr. Berianu graduated from Carol Davila University of Medicine and Pharmacy in 1998. Dr. Berianu holds Florida license ME113458.

Dr. Berianu's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Berianu's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berianu practices. Vendor and product names are available with a free account.

Rheumatology is Dr. Berianu's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Berianu is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Berianu's licenses on file in 3 states: Florida, Georgia and Wisconsin.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, joint pain, muscle disease, muscle pain, fibromyalgia, and limb pain and rheumatoid arthritis among the conditions Dr. Berianu treats.

CMS data shows 285 Medicare services from Dr. Berianu across 8 procedure codes in 2024, for 234 Medicare patients. Medicare paid $21,862 for them. Every service was in an office.

CMS counts 234 Medicare patients who saw Dr. Berianu in 2024. The largest group is 65 to 74, with 113 patients. 75% of them have arthritis, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berianu's median patient age at 56, with 74% women.

In 2024, Dr. Berianu wrote 323 Medicare Part D claims for 101 patients. 79% of them were for generic drugs. CMS names the drug for 230 of them, across 7 drugs with 11 or more claims each, at $178,361 in total drug cost. In 2023, CMS named 235 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Berianu for performance year 2024, reported as part of a group. Dr. Berianu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Berianu as offering telehealth.

Dmand AI links 36 papers to Dr. Berianu, published from 2013 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Fasciitis, Magnetic Resonance Imaging and Sarcoidosis. Dr. Berianu has published most often in Cureus. Dr. Berianu's most frequent co-authors are Andy Abril, MD, Sehreen Mumtaz, MD and Ronald R. Butendieck, MD.

CMS Open Payments shows 14 general payments to Dr. Berianu from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $479.

Dr. Berianu graduated from Carol Davila University of Medicine and Pharmacy in 1998. Dr. Berianu is a member of ACR.

Dr. Berianu is in network with 10 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. POS plans come from the most carriers, 6. Check the plan with the practice before a visit.